News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
710,134 Results
Type
Article (41330)
Company Profile (257)
Press Release (668545)
Multimedia
Podcasts (101)
Webinars (18)
Section
Business (205484)
Career Advice (2091)
Deals (35593)
Drug Delivery (99)
Drug Development (81344)
Employer Resources (186)
FDA (16309)
Job Trends (14972)
News (347198)
Policy (32707)
Tag
Academia (2623)
Accelerated approval (9)
Adcomms (22)
Allergies (95)
Alliances (49981)
ALS (108)
Alzheimer's disease (1452)
Antibody-drug conjugate (ADC) (154)
Approvals (16307)
Artificial intelligence (338)
Autoimmune disease (29)
Automation (18)
Bankruptcy (363)
Best Places to Work (11706)
BIOSECURE Act (19)
Biosimilars (121)
Biotechnology (182)
Bladder cancer (93)
Brain cancer (33)
Breast cancer (364)
Cancer (2867)
Cardiovascular disease (209)
Career advice (1750)
Career pathing (33)
CAR-T (184)
CDC (30)
Cell therapy (501)
Cervical cancer (22)
Clinical research (66965)
Collaboration (1033)
Company closure (3)
Compensation (683)
Complete response letters (21)
COVID-19 (2641)
CRISPR (57)
C-suite (327)
Cystic fibrosis (113)
Data (2988)
Decentralized trials (2)
Denatured (51)
Depression (59)
Diabetes (347)
Diagnostics (6515)
Digital health (24)
Diversity (10)
Diversity, equity & inclusion (47)
Drug discovery (142)
Drug pricing (123)
Drug shortages (29)
Duchenne muscular dystrophy (125)
Earnings (87648)
Editorial (41)
Employer branding (24)
Employer resources (158)
Events (114577)
Executive appointments (860)
FDA (17963)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (933)
Gene editing (130)
Generative AI (25)
Gene therapy (381)
GLP-1 (781)
Government (4518)
Grass and pollen (4)
Guidances (181)
Healthcare (19021)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (146)
Immuno-oncology (8)
Indications (39)
Infectious disease (2812)
Inflammatory bowel disease (148)
Inflation Reduction Act (12)
Influenza (62)
Intellectual property (119)
Interviews (332)
IPO (16653)
IRA (47)
Job creations (3649)
Job search strategy (1475)
Kidney cancer (13)
Labor market (56)
Layoffs (496)
Leadership (24)
Legal (7939)
Liver cancer (80)
Lung cancer (400)
Lymphoma (207)
Machine learning (11)
Management (61)
Manufacturing (382)
MASH (91)
Medical device (13569)
Medtech (13574)
Mergers & acquisitions (19652)
Metabolic disorders (849)
Multiple sclerosis (99)
NASH (16)
Neurodegenerative disease (113)
Neuropsychiatric disorders (32)
Neuroscience (2127)
NextGen: Class of 2025 (6591)
Non-profit (4538)
Now hiring (48)
Obesity (425)
Opinion (227)
Ovarian cancer (100)
Pain (105)
Pancreatic cancer (120)
Parkinson's disease (186)
Partnered (22)
Patents (297)
Patient recruitment (162)
Peanut (50)
People (58175)
Pharmaceutical (63)
Pharmacy benefit managers (21)
Phase I (20870)
Phase II (29498)
Phase III (21939)
Pipeline (1623)
Policy (201)
Postmarket research (2571)
Preclinical (8887)
Press Release (66)
Prostate cancer (140)
Psychedelics (35)
Radiopharmaceuticals (255)
Rare diseases (458)
Real estate (5932)
Recruiting (70)
Regulatory (22703)
Reports (61)
Research institute (2383)
Resumes & cover letters (358)
Rett syndrome (9)
RNA editing (9)
RSV (49)
Schizophrenia (86)
Series A (157)
Series B (108)
Service/supplier (11)
Sickle cell disease (60)
Special edition (19)
Spinal muscular atrophy (148)
Sponsored (33)
Startups (3621)
State (2)
Stomach cancer (14)
Supply chain (75)
Tariffs (57)
The Weekly (48)
Vaccines (781)
Venture capital (53)
Weight loss (257)
Women's health (50)
Worklife (19)
Date
Last 7 days (376)
Last 30 days (1795)
Last 365 days (31538)
2025 (16834)
2024 (35544)
2023 (40382)
2022 (51454)
2021 (56039)
2020 (54459)
2019 (47023)
2018 (35358)
2017 (32382)
2016 (31749)
2015 (37814)
2014 (31531)
2013 (26605)
2012 (28821)
2011 (29464)
2010 (27522)
Location
Africa (729)
Alabama (62)
Alaska (7)
Arizona (245)
Arkansas (14)
Asia (38474)
Australia (6290)
California (7440)
Canada (2360)
China (671)
Colorado (322)
Connecticut (323)
Delaware (192)
Europe (83284)
Florida (1117)
Georgia (249)
Hawaii (1)
Idaho (59)
Illinois (640)
India (26)
Indiana (362)
Iowa (16)
Japan (227)
Kansas (108)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1028)
Massachusetts (5530)
Michigan (245)
Minnesota (450)
Mississippi (3)
Missouri (89)
Montana (29)
Nebraska (25)
Nevada (80)
New Hampshire (66)
New Jersey (2076)
New Mexico (28)
New York (2098)
North Carolina (1103)
North Dakota (8)
Northern California (3266)
Ohio (238)
Oklahoma (16)
Oregon (37)
Pennsylvania (1613)
Puerto Rico (17)
Rhode Island (36)
South America (1107)
South Carolina (34)
South Dakota (1)
Southern California (2782)
Tennessee (125)
Texas (1125)
United States (27631)
Utah (222)
Virginia (185)
Washington D.C. (72)
Washington State (635)
West Virginia (4)
Wisconsin (65)
710,134 Results for "magnetic insight inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville
June 17, 2025
·
8 min read
Business
A Conversation with Peter Marks: Insights into GenScript Biotech Forum 2025
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis talks to Dr. Peter Marks, Director, CBER about his thoughts on the future of cell and gene therapies.
January 16, 2025
·
1 min read
·
Lori Ellis
Business
Navigating Funding Freezes and AI Frontiers
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis discusses key themes from BIO and DIA, including the funding environment, with Rich Daly, CEO of Catalyst Pharmaceuticals, Peter Ronco, CEO of Emmes Corporation, and Phil Vanek, founder of Redline Bio Advisors.
June 20, 2025
·
1 min read
·
Lori Ellis
Business
A Conversation with Peter Marks and Tom Whitehead: Insights into GenScript Biotech Forum 2025 (Teaser)
In this short teaser, BioSpace’s Head of Insights Lori Ellis talks to CBER Director Peter Marks and Tom Whitehead, Co-Founder of the Emily Whitehead Foundation about anticipated discussions at the upcoming GenScript Biotech Forum.
January 10, 2025
·
1 min read
·
Lori Ellis
Press Releases
Gene Editing Market to be Worth USD 9.51 Billion by 2032: Coherent Market Insights, Inc.
May 15, 2025
·
1 min read
IN PARTNERSHIP WITH ECLIPSEBIO
The mRNA Revolution You Haven’t Heard About: From Cystic Fibrosis to Personalized Cancer Vaccines
In this episode presented by Eclipsebio, BioSpace’s head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines, and Pad Chivukula of Arcturus Therapeutics.
July 10, 2025
·
1 min read
·
Lori Ellis
IN PARTNERSHIP WITH DIA
Balancing Protection and Inclusion: The Evolution of Women in Clinical Trials
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses the evolution of women’s inclusion in clinical trials with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
March 27, 2025
·
1 min read
·
Lori Ellis
Drug Development
Trust, Tech, and Tomorrow: A Pharmaceutical Executive’s WEF Insights
Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
March 5, 2025
·
1 min read
·
Lori Ellis
IN PARTNERSHIP WITH CHARLES RIVER LABORATORIES
Cell and Gene Therapy Sector Sees 30% Investment Surge Despite Market Challenges
Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts explored at Charles River Laboratories’ 2025 Cell & Gene Therapy Summit.
March 31, 2025
·
5 min read
·
BioSpace Insights
IN PARTNERSHIP WITH IQVIA
Understanding the FDA’s AI Guidance in Pharmacovigilance
In this episode presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses the FDA’s first draft guidance for AI in drug development, published in January 2025, with Archana Hegde, senior director, pv systems and innovations at IQVIA.
July 1, 2025
·
1 min read
·
Lori Ellis
1 of 71,014
Next
